Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint

European Journal of Pain

Volumn 13, Issue 8, 2009, Pages 812-819

  Denadai Souza, Alexandre ^a   Camargo, Livia de Lucca ^a   Ribela, Maria T C P ^b   Keeble, Julie E ^c   Costa, Soraia K P ^a   Muscará, Marcelo N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arthritis; Neurogenic inflammation; NK1 receptors; Substance P; Temporomandibular joint

Indexed keywords

CARRAGEENAN; INTERLEUKIN 1BETA; NEUROKININ 1 RECEPTOR; NOLPITANTIUM; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EXTRAVASATION; JOINT CAVITY; LEUKOCYTE; LEUKOCYTE COUNT; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; TEMPOROMANDIBULAR JOINT INFLAMMATION;

ANIMALS; CARRAGEENAN; DATA INTERPRETATION, STATISTICAL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; INFLAMMATION; INTERLEUKIN-1BETA; LEUKOCYTE COUNT; MALE; PAIN; PEROXIDASE; PIPERIDINES; QUINUCLIDINES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; SERUM ALBUMIN, RADIO-IODINATED; SUBSTANCE P; TEMPOROMANDIBULAR JOINT DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67949083377     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.09.012     Document Type: Article

References (64)

1. Ahluwalia A., De Felipe C., O'Brien J., Hunt S.P., and Perretti M. Impaired IL-1beta-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice. Br J Pharmacol 124 (1998) 1013-1015
2. Amann R., Schuligoi R., Holzer P., and Donnerer J. The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 201-205
3. Ansel J.C., Brown J.R., Payan D.G., and Brown M.A. Substance P selectively activates TNFa gene expression in murine mast cells. J Immunol 150 (1993) 4478-4483
4. Appelgren A., Appelgren B., Eriksson S., Kopp S., Lundeberg T., Nylander M., et al. Neuropeptides in temporomandibular joints with rheumatoid arthritis: a clinical study. Scand J Dent Res 99 (1991) 519-521
5. Atsü S.S., and Ayhan-Ardic F. Temporomandibular disorders seen in rheumatology practices: a review. Rheumatol Int 26 (2006) 781-787
6. Bakke M., Hu J.W., and Sessle B.J. Involvement of NK-1 and NK-2 tachykinin receptor mechanisms in jaw muscle activity reflexly evoked by inflammatory irritant application to the rat temporomandibular joint. Pain 75 (1998) 219-227
7. Biscayart P.L., Paladini A.C., Vita N., and Roguin L.P. Preparation of 125I-labeled human growth hormone of high quality binding properties endowed with long-term stability. J Immunoassay 10 (1989) 37-56
8. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
9. Brain S.D. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 37 (1997) 133-152
10. Bucci M., Roviezzo F., Posadas I., Yu J., Parente L., Sessa W.C., et al. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA 102 (2005) 904-908
11. Cao T., Pintér E., Al-Rashed S., Gerard N., Hoult J.R., and Brain S.D. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice. J Immunol 164 (2000) 5424-5429
12. Carleson J., Alstergren P., Appelgren A., Appelgren B., Kopp S., Srinivasan G.R., et al. Effects of adjuvant on neuropeptide-like immunoreactivity in experimentally induced temporomandibular arthritis in rats. Arch Oral Biol 41 (1996) 705-712
13. Casatti C.A., Frigo L., and Bauer J.A. Origin of sensory and autonomic innervation of the rat temporomandibular joint: a retrograde axonal tracing study with the fluorescent dye fast blue. J Dent Res 78 (1999) 776-783
14. Castro A.R., Pinto M., Lima D., and Tavares L. Secondary hyperalgesia in the monoarthritic rat is mediated by GABAB and NK1 receptors of spinal dorsal horn neurons: a behavior and c-fos study. Neuroscience 141 (2006) 2087-2095
15. Cocchiara R., Bongiovanni A., Albeggiani G., Azzolina A., and Geraci D. Substance P selectively activates TNFalpha mRNA in rat uterine immune cells: a neuroimmune link. Neuroreport 8 (1997) 2961-2964
16. Costa S.K., de Nucci G., Antunes E., and Brain S.D. Phoneutria nigriventer spider venom induces oedema in rat skin by activation of capsaicin sensitive sensory nerves. Eur J Pharmacol 339 (1997) 223-226
17. Costa S.K., Yshii L.M., Poston R.N., Muscará M.N., and Brain S.D. Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFalpha in the cutaneous microvasculature. J Neuroimmunol 171 (2006) 99-109
18. Costa S.K., Starr A., Hyslop S., Gilmore D., and Brain S.D. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom. Vascul Pharmacol 45 (2006) 209-214
19. Dickerson C., Undem B., Bullock B., and Winchurch R.A. Neuropeptide regulation of proinflammatory cytokine responses. J Leukoc Biol 63 (1998) 602-605
20. Egan C.G., Lockhart J.C., Ferrell W.R., Day S.M., and McLean J.S. Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2. J Physiol 539 (2002) 579-587
21. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 52 (2008) 40-51
22. Feldmann M., and Maini R.N. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology 38 (1999) 3-7
23. Franco-Penteado C.F., De Souza I.A., Camargo E.A., Teixeira S.A., Muscará M.N., De Nucci G., et al. Mechanisms involved in the enhancement of allergic airways neutrophil influx by permanent C-fiber degeneration in rats. J Pharmacol Exp Ther 313 (2005) 440-448
24. Franco-Penteado C.F., De Souza I.A., Lima C.S., Teixeira S.A., Muscará M.N., De Nucci G., et al. Effects of neonatal capsaicin treatment in the neutrophil production, and expression of preprotachykinin-I and tachykinin receptors in the rat bone marrow. Neurosci Lett 407 (2006) 70-73
25. Fries J.F. How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments?. Rheumatology 38 (1999) 35-40
26. Gao Y.J., Zhang Y.Q., and Zhao Z.Q. Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat. Brain Res Bull 61 (2003) 587-593
27. Goulart A.C., Correia F.A.S., Sousa S.C.O.M., and Luz J.G.C. Study of the inflammatory process induced by injection of carrageenan or formalin in the rat temporomandibular joint. Braz Oral Res 19 (2005) 99-105
28. Grant A.D., Akhtar R., Gerard N.P., and Brain S.D. Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms. J Physiol 543 (2002) 1007-1014
29. Haeuchi Y., Matsumoto K., Ichikawa H., and Maeda S. Immunohistochemical demonstration of neuropeptides in the articular disk of the human temporomandibular joint. Cell Tissue Org 164 (1999) 205-211
30. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., and Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159 (1997) 5654-5660
31. Holmlund A., Ekblom A., Hansson P., Lind J., Lundeberg T., Theodorsson E., et al. Calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings. Int J Oral Maxillofac Surg 20 (1991) 228-231
32. Kaneyama K., Segami N., Sato J., Fujimura K., Nagao T., and Yoshimur H. Prognostic factors in arthrocentesis of the temporomandibular joint: comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases. J Oral Maxillofac Surg 65 (2007) 242-247
33. Keeble J., Blades M., Pitzalis C., Castro da Rocha F.A., and Brain S.D. The role of substance P in microvascular responses in murine joint inflammation. Br J Pharmacol 144 (2005) 1059-1066
34. Keeble J., Russell F., Curtis B., Starr A., Pinter E., and Brain S.D. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum 52 (2005) 3248-3256
35. Kido M.A., Kiyoshima T., Kondo T., Ayasaka N., Moroi R., Terada Y., et al. Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat temporomandibular joint. J Dent Res 72 (1993) 592-598
36. Koon H.W., and Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 1088 (2006) 23-40
37. Lai J.P., Douglas S.D., and Ho W.Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol 86 (1998) 80-86
38. Laurenzi M.A., Persson M.A., Dalsgaard C.J., and Haegerstrand A. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide. Scand J Immunol 31 (1990) 529-533
39. Lee H.R., Ho W.Z., and Douglas S.D. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin Diagn Lab Immunol 1 (1994) 419-423
40. Levine J.D., Khasar S.G., and Green P.G. Neurogenic inflammation and arthritis. Ann NY Acad Sci 1069 (2006) 155-167
41. Lotz M., Vaughan J.H., and Crason D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241 (1988) 1218-1220
42. Lundeberg T., Alstergren P., Appelgren A., Appelgren B., Carleson J., Kopp S., et al. A model for experimentally induced temporomandibular joint arthritis in rats: effects of carrageenan on neuropeptide-like immunoreactivity. Neuropeptides 30 (1996) 37-41
43. Maggi C.A., and Schwartz T.W. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci 18 (1997) 351-355
44. Marshall K.W., Chiu B., and Inman R.D. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum 33 (1990) 87-90
45. Posadas I., Bucci M., Roviezzo F., Rossi A., Parente L., Sautebin L., et al. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol 142 (2004) 331-338
46. Radhakrishnan R., Moore S.A., and Sluka K.A. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 104 (2003) 567-577
47. Rawlingson A., Costa S.K., and Brain S.D. Role of tachykinins in neurogenic inflammation of the skin and other external surfaces (rev). Handbook of Experimental Pharmacology 164 (2004) 459-490
48. Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav 67 (1999) 711-716
49. Rupniak N.M., Tattersall F.D., Williams A.R., Rycroft W., Carlson E.J., Cascieri M.A., et al. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. Eur J Pharmacol 326 (1997) 201-209
50. Sandler C., Lindstedt K.A., Joutsiniemi S., Lappalainen J., Juutilainen T., Kolah J., et al. Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra. Inflamm Res 56 (2007) 230-239
51. Sato J., Segami N., Yoshitake Y., Kaneyama K., Yoshimura H., Fujimura K., et al. Specific expression of substance P in synovial tissues of patients with symptomatic, non-reducing internal derangement of the temporomandibular joint: comparison with clinical findings. Br J Oral Maxillofac Surg 45 (2007) 372-377
52. Sessle B.J. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 11 (2000) 57-91
53. Sluka K.A., Milton M.A., Willis W.D., and Westlund K.N. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol 120 (1997) 1263-1273
54. Ta L.E., and Dionne R.A. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain 111 (2004) 13-21
55. Takeda M., Tanimoto T., Ikeda M., Nasu M., Kadoi J., Shima Y., et al. Temporomandibular joint inflammation potentiates the excitability of trigeminal root ganglion neurons innervating the facial skin in rats. J Neurophysiol 93 (2005) 2723-2738
56. Takeda M., Tanimoto T., Nasu M., Ikeda M., Kadoi J., and Matsumoto S. Activation of NK1 receptor of trigeminal root ganglion via substance P paracrine mechanism contributes to the mechanical allodynia in the temporomandibular joint inflammation in rats. Pain 116 (2005) 375-385
57. Tambeli C.H., Seo K., Sessle B.J., and Hu J.W. Central mu opioid receptor mechanisms modulate mustard oil-evoked jaw muscle activity. Brain Res 913 (2001) 90-94
58. Uddman R., Grunditz T., Kato J., and Sundler F. Distribution and origin of nerve fibers in the rat temporomandibular joint capsule. Anat Embryol 197 (1998) 273-282
59. Vivancos G.G., Verri Jr. W.A., Cunha T.M., Schivo I.R., Parada C.A., Cunha F.Q., et al. An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 37 (2004) 391-399
60. Voog U., Alstergren P., Leibur E., Kallikorm R., and Kopp S. Impact of temporomandibular joint pain on activities of daily living in patients with rheumatoid arthritis. Acta Odontol Scand 61 (2003) 278-282
61. Widenfalk B., and Wiberg M. Origin of sympathetic and sensory innervation of the temporo-mandibular joint. A retrograde axonal tracing study in the rat. Neurosci Lett 109 (1990) 30-35
62. Yu X.M., Sessle B.J., Haas D.A., Izzo A., Vernon H., and Hu J.W. Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats. Pain 68 (1996) 169-178
63. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
64. Zwerina J., Redlich K., Polzer K., Joosten L., Krönke G., Distler J., et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 104 (2007) 11742-11747